as on February 2, 2026 at 8:40 pm IST
Day's Low
Day's High
2.41%
Downside
1.66%
Upside
52 Week's Low
52 Week's High
22.07%
Downside
19.42%
Upside
Check Exelixis, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$11.8B
EPS (TTM)
2.9539
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.72%
PE Ratio (TTM)
18.38
Industry PE ratio
5.33235294117647
PEG Ratio
2.2685
EBITDA
850.0M
Revenue (TTM)
2.3B
Profit Margin
29.63%
Return On Equity TTM
30.56%
Track how Exelixis, Inc. P/E has moved over time to understand its valuation trends.
Exelixis, Inc. in the last 5 years
Lowest (15.15x)
September 30, 2024
Industry (5.33x)
February 2, 2026
Today (18.38x)
February 2, 2026
Highest (122.74x)
April 30, 2021
Today’s Price to Earnings Ratio: 18.38x
Compare market cap, revenue, PE, and other key metrics of Exelixis, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $11.8B | 83.33% | 18.38 | 29.63% | |
| BUY | $122.3B | 116.21% | 33.56 | 31.35% | |
| BUY | $47.7B | 119.45% | 1246.03 | 1.36% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 48.3% | 18.28 | 32.13% |
The Exelixis, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Exelixis, Inc. investment value today
Current value as on today
₹1,30,532
Returns
₹30,532
(+30.53%)
Returns from Exelixis, Inc. Stock
₹25,339 (+25.34%)
Dollar Returns*
₹5,193 (+5.19%)
Based on 26 analysts
76.92%
Buy
19.23%
Hold
3.85%
Sell
Based on 26 analysts, 76.92% of analysts recommend a 'BUY' rating for Exelixis, Inc.. Average target price of $45.78
Get share price movements and forecasts by analysts on Exelixis, Inc..
What analysts predicted
9.24%UPSIDE
Target Price
$45.78
Current Price
$41.55
Analyzed by
26 Analysts
Target
$45.78
Exelixis, Inc. target price $45.78, a slight upside of 9.24% compared to current price of $41.55. According to 26 analysts rating.
Search interest for Exelixis, Inc. Stock has decreased by -27% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 20 October
Mon, 12:00 PM
-Exelixis announces detailed results from STELLAR-303 trial, showing zanzalintinib improves overall survival to 10.9 months versus regorafenib.
Mon, 08:18 PM
-Exelixis stock drops 12.17% after sharing detailed results from STELLAR-303 trial, despite positive overall survival findings.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 5 quarters, 117.97M → 193.57M (in $), with an average increase of 11.6% per quarter
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 555.44M → 597.75M (in $), with an average increase of 3.6% per quarter
Best in 3 Years
![]()
In the last 3 years, EXEL has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 3 years, EXEL stock has moved up by 134.9%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 51.3% return, outperforming this stock by 26.5%
| Organisation | Exelixis, Inc. |
| Headquarters | 1851 Harbor Bay Parkway, Alameda, CA, United States, 94502 |
| Industry | Health Technology |
| CEO | Dr. Michael M. Morrissey Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Dana T. Aftab Ph.D. | Executive Vice President of Research & Development |
Dr. Brenda Hefti J.D., Ph.D. | Senior VP & General Counsel |
Dr. Stefan Krauss Ph.D. | VP & Head of Business Development |
Ms. Susan T. Hubbard | Executive Vice President of Public Affairs & Investor Relations |
Dr. Anne Champsaur M.D. | Senior Vice President of Drug Safety |
Dr. William Berg M.D. | Senior Vice President of Medical Affairs |
Mr. Patrick Joseph Haley M.B.A. | Executive Vice President of Commercial |
Dr. Stelios Papadopoulos Ph.D. | Co-Founder & Independent Chair of the Board |
Dr. Michael M. Morrissey Ph.D. | CEO, President & Director |
Mr. Christopher J. Senner | Executive VP & CFO |
Exelixis, Inc. share price today is $41.55 as on . Exelixis, Inc. share today touched a day high of $42.24 and a low of $40.55.
Exelixis, Inc. share touched a 52 week high of $49.62 on and a 52 week low of $32.38 on . Exelixis, Inc. stock price today i.e. is trending at $41.55,which is 16.26% down from its 52 week high and 28.32% up from its 52 week low.
Exelixis, Inc. market capitalisation is $0.01T as on .
Indian investors can start investing in Exelixis, Inc. (EXEL) shares with as little as ₹91.486 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹914.86 in Exelixis, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Exelixis, Inc. share’s latest price of $41.55 as on February 2, 2026 at 8:40 pm IST, you will get 0.2407 shares of Exelixis, Inc.. Learn more about
fractional shares .
Exelixis, Inc. stock has given 83.33% share price returns and 25.75% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?